Candel Therapeutics, Inc. (Nasdaq: CADL) announced that an abstract was accepted for poster presentation at the 2026 American Society for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE